INCY
Price
$83.11
Change
+$0.01 (+0.01%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
16.24B
49 days until earnings call
Interact to see
Advertisement

INCY

Header iconINCY Comparison
Open Charts INCYBanner chart's image
Incyte
Price$83.11
Change+$0.01 (+0.01%)
Volume$34.75K
Capitalization16.24B
INCY Comparison Chart in %
Loading...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.9B. The market cap for tickers in the group ranges from 58 to 100.82B. VRTX holds the highest valuation in this group at 100.82B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 34%. BVAXD experienced the highest price growth at 915%, while ATYR experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -29% and the average quarterly volume growth was 95%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 82
Price Growth Rating: 57
SMR Rating: 93
Profit Risk Rating: 94
Seasonality Score: -23 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (INCY: $83.14)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCY’s FA Score shows that 0 FA rating(s) are green while.

  • INCY’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCY’s TA Score shows that 3 TA indicator(s) are bullish.

  • INCY’s TA Score: 3 bullish, 5 bearish.

Price Growth

INCY (@Biotechnology) experienced а -3.95% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +6.67%, and the average quarterly price growth was +33.69%.

Reported Earning Dates

INCY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCY
Capitalization16.2B
EBITDA1.36B
Gain YTD20.371
P/E Ratio19.65
Revenue4.59B
Total Cash2.42B
Total Debt42.4M
FUNDAMENTALS RATINGS
INCY: Fundamental Ratings
INCY
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INCY
RSI
ODDS (%)
Bearish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
59%
Momentum
ODDS (%)
Bearish Trend 4 days ago
55%
MACD
ODDS (%)
Bearish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
61%
Advances
ODDS (%)
Bullish Trend 13 days ago
61%
Declines
ODDS (%)
Bearish Trend 4 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
60%
Aroon
ODDS (%)
Bullish Trend 4 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OILK40.600.38
+0.94%
ProShares K-1 Free Crude Oil ETF
RMM13.920.10
+0.73%
RiverNorth Managed Duration Municipal Income Fund
RVRB34.680.19
+0.54%
Reverb ETF
MYCI25.150.03
+0.12%
SPDR SSGA My2029 Corporate Bond ETF
DFAR23.93-0.09
-0.37%
Dimensional US Real Estate ETF

INCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with TECH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
+0.05%
TECH - INCY
42%
Loosely correlated
+0.70%
AXON - INCY
39%
Loosely correlated
+0.62%
REGN - INCY
38%
Loosely correlated
+2.25%
LGND - INCY
37%
Loosely correlated
-0.14%
SYRE - INCY
37%
Loosely correlated
-5.18%
More